Welcome to isctr.org


ISCTR - TCT 2017 Consensus Summit

Building on the success of last year’s symposium, the ISCTR Board of Directors invite you to the ISCTR – TCT 2017 Consensus Summit on Clinical Endpoints/Surrogates and Effect Size for Approval of Cardiovascular Devices, being held Sunday, October 29, 2017, in Denver, Colorado. Presenting the Keynote Address will be Sir Professor Magdi Yacoub, MD, FRS, OM, who will be speak on Ventricular Assist Devices: The Windy Road to Recovery.

The International Liaison to the ISCTR Governing Board, Dr. Yacoub is Professor of Cardiothoracic Surgery at the National Heart and Lung Institute, Imperial College London, and Founder and Director of Research at the Harefield Heart Science Centre, where he oversees more than 60 scientists and students in the areas of tissue engineering, myocardial regeneration, stem cell biology, end stage heart failure and transplant immunology. He is also Founder and Director of Magdi Yacoub Research Network which has created the Qatar Cardiovascular Research Center. In addition, he founded the Aswan Heart Center to be the hub of the Middle East for advanced adult and congenital cardiac surgery.

Professor Yacoub was born in Egypt and graduated from Cairo University Medical School in 1957, trained in London, and held an assistant professorship at the University of Chicago. He also has served as a professor of cardiothoracic surgery for more than 20 years and was a consultant cardiothoracic surgeon at Harefield Hospital from 1969-2001 and Royal Brompton Hospital from 1986-2001. Professor Yacoub established the largest heart and lung transplantation program in the world where more than 2,500 transplant operations have been performed. He has also developed novel operations for a number of complex congenital heart anomalies. He was knighted for his services to medicine and surgery in 1991, awarded Fellowship of the Academy of Medical Sciences in 1998 and Fellowship of The Royal Society in 1999. More information about Dr. Yacoub is available here.


Update: Consensus Strategies for Device Development for Cardiovascular Disease

Based on the conversations begun at our consensus summit at the 2016 TCT meeting, ISCTR is collaborating with innovators, regulators, industry leaders, and others to create strategies and methodologies designed to achieve the rapid and cost-effective translation of cardiovascular device advances into clinical practice.

Working groups comprised of experts in the their field have been formed to focus on specific areas of device development and implementation. The group dedicated to an overview of the translational pathway is being chaired by David R. Holmes, Jr., MD, MACC, while separate groups will concentrate on breaking down the methodologies involved in the development of aortic/pulmonic valves, led by Stanton Rowe; mitral/tricuspid valves, headed by Michael Mack, MD, FACC; stents, steered by Charles Simonton, MD, FACC; and catheter ablation devices, led by Douglas Packer, MD. These groups have been developing their sections and we expect to convene a meeting at the Food and Drug Administration this fall to review their critical efforts.

Check back often to get more details about this meeting and the development of the documentation of these strategies as they are available. You can learn more about the genesis of this meeting through our coverage of our 2016 TCT summit here.

Cardiovascular Translational Research eTextbook



Available now for iPad and web browsers.

ESC Congress 2017

ISCTR President Nabil Dib, MD, MSc, FACC

presented “The Optimal Process of Translating Basic Innovations into Clinical Care” during a session on Developments in Cardiovascular Translation Research that also featured Eugene Braunwald, MD, MACC, MACP, ISCTR Vice President Anthony DeMaria, MD, MACC, and ISCTR Board Member Robert Roberts, MD, FACC.


View presentations from the 9th Annual ISCTR Symposium

Become an ISCTR Member

In Translation

An ISCTR member publication

Clinical Trials

Find announcements and information about upcoming and existing clinical trials, as well as links to other sources on the internet…


9th Annual Symposium summary information and presentation videos …

In the News

Check here for our latest press releases and media contact information …


International Society for
Cardiovascular Translational Research

The International Society for Cardiovascular Translational Research (ISCTR) is a non-profit organization that was founded in 2007 by Dr Nabil Dib with a goal to expedite scientific discovery to clinical application (patients).

Read more…

The Glen and Marilyn Nelson Award for Innovation and Translation in Cardiovascular Medicine


Click to view ->

Journal of Cardiovascular Translational Research


Click for details on Springer…